Atlas Trials

Interferon-α After DLI for the Prevention of Relapse

Clinical trial NCT02568241 · UNKNOWN

Trial details

NCT number
NCT02568241
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2015-12-01
Primary completion
2017-12-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.